CUPERTINO, Calif.--(BUSINESS WIRE)--BioImagene, the leading provider of digital pathology solutions, today introduced 3i, a web based platform for developing imaging applications for Digital Pathology and Drug Discovery. At the core of 3i are three powerful modules of Image Management, Image Processing and Image Analysis, with built-in services for integration and collaboration. 3i is built on patented technologies from SIMS and TissueAnalytics platforms, from BioImagene’s acquisitions of Scimagix and Tissue Informatics. The 3i architecture is optimized for acquiring, archiving, analysis, management, reporting and sharing of image data, for a seamless information flow.
